935283-04-8
935283-04-8
林扎戈利
935283-04-8海关数据
别名：
3-[5-[(2,3-二氟-6-甲氧基苯基)甲氧基]-2-氟-4-甲氧基苯基]-1,2,3,4-四氢-2,4-二氧代噻吩并[3,4-D]嘧啶-5-羧酸; 化合物LINZAGOLIX; 3-[5-[(2,3-二氟-6-甲氧基苯基)甲氧基]-2-氟-4-甲氧基苯基]-1,2,3,4-四氢-2,4-二氧代噻吩并[3,4-d]嘧啶-5-羧酸
英文名：
Zavegepant Impurity 55
; Obe2109; Obe 2109; Klh2109; Klh 2109; Klh 2109,Endometriosis,Klh-2109,Gnrh Receptor,Gonadotropin Releasing Hormone Receptor,Inhibit,Uterine Fibroids,Klh2109,Linzagolix,Gnrhr,Adenomyosis,Obe 2109,Inhibitor,Obe-2109,Obe2109; 3-[5-[(2,3-Difluoro-6-Methoxyphenyl)Methoxy]-2-Fluoro-4-Methoxyphenyl]-1,2,3,4-Tetrahydro-2,4-Dioxothieno[3,4-D]Pyrimidine-5-Carboxylic Acid; Linzagolix; Klh-2109; Obe-2109; Thieno[3,4-D]Pyrimidine-5-Carboxylic Acid, 3-[5-[(2,3-Difluoro-6-Methoxyphenyl)Methoxy]-2-Fluoro-4-Methoxyphenyl]-1,2,3,4-Tetrahydro-2,4-Dioxo-; 3-[5-[(2,3-Difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-1,2,3,4-tetrahydro-2,4-dioxothieno[3,4-d]pyrimidine-5-carboxylic acid
分子式：
935283-04-8供应信息
| 供应商 | 纯度 | 点赞 | 查看 |
|---|---|---|---|
| 济南大象药物研究有限公司 |
|
查看详情 |